ATE241991T1 - Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthält - Google Patents

Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthält

Info

Publication number: ATE241991T1
Authority: AT; Austria
Prior art keywords: antimetabolites; composition containing; synergistic composition; daunorubicin derivatives; containing daunorubicin
Prior art date: 1999-07-19

Application number

AT00949297T

Other languages

English (en)

Inventor

Maria Cristina Geroni

Marina Ripamonti

Michele Caruso

Antonino Suarato

Original Assignee

Pharmacia Italia Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-19

Filing date

2000-07-10

Publication date

2003-06-15

2000-07-10 Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa

2003-06-15 Application granted granted Critical

2003-06-15 Publication of ATE241991T1 publication Critical patent/ATE241991T1/de

Links

STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical class O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 title abstract 3
229940100197 antimetabolite Drugs 0.000 title abstract 2
239000002256 antimetabolite Substances 0.000 title abstract 2
230000002195 synergetic effect Effects 0.000 title 1
STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 2
229960000975 daunorubicin Drugs 0.000 abstract 2
206010027476 Metastases Diseases 0.000 abstract 1
230000000340 anti-metabolite Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000009401 metastasis Effects 0.000 abstract 1
230000014399 negative regulation of angiogenesis Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT00949297T 1999-07-19 2000-07-10 Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthält ATE241991T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9916882.5A GB9916882D0 (en)	1999-07-19	1999-07-19	Antitumor synergistic composition
PCT/EP2000/006545 WO2001005382A1 (en)	1999-07-19	2000-07-10	Synergistic composition comprising daunorubicin derivatives and antimetabolite compounds

Publications (1)

Publication Number	Publication Date
ATE241991T1 true ATE241991T1 (de)	2003-06-15

Family

ID=10857494

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00949297T ATE241991T1 (de)	1999-07-19	2000-07-10	Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthält

Country Status (10)

Country	Link
EP (1)	EP1200099B1 (de)
JP (1)	JP2003504394A (de)
AT (1)	ATE241991T1 (de)
AU (1)	AU6271100A (de)
DE (1)	DE60003189T2 (de)
DK (1)	DK1200099T3 (de)
ES (1)	ES2195922T3 (de)
GB (1)	GB9916882D0 (de)
PT (1)	PT1200099E (de)
WO (1)	WO2001005382A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0114654D0 (en) *	2001-06-15	2001-08-08	Pharmacia & Upjohn Spa	Anti-tumor compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4853221A (en) *	1980-11-13	1989-08-01	Warner-Lambert Company	Method for treating non-small cell lung cancer, head and neck cancers and breast cancer
US5919816A (en) *	1994-11-14	1999-07-06	Bionumerik Pharmaceuticals, Inc.	Formulations and methods of reducing toxicity of antineoplastic agents
GB9806324D0 (en) *	1998-03-24	1998-05-20	Pharmacia & Upjohn Spa	Antitumour synergetic composition
GB9904387D0 (en) *	1999-02-25	1999-04-21	Pharmacia & Upjohn Spa	Antitumour synergistic composition
GB9904386D0 (en) *	1999-02-25	1999-04-21	Pharmacia & Upjohn Spa	Antitumour synergistic composition
GB9909925D0 (en) *	1999-04-29	1999-06-30	Pharmacia & Upjohn Spa	Combined preparations comprising anthracycline derivatives

1999
- 1999-07-19 GB GBGB9916882.5A patent/GB9916882D0/en not_active Ceased
2000
- 2000-07-10 DK DK00949297T patent/DK1200099T3/da active
- 2000-07-10 AU AU62711/00A patent/AU6271100A/en not_active Abandoned
- 2000-07-10 JP JP2001510439A patent/JP2003504394A/ja not_active Withdrawn
- 2000-07-10 ES ES00949297T patent/ES2195922T3/es not_active Expired - Lifetime
- 2000-07-10 AT AT00949297T patent/ATE241991T1/de not_active IP Right Cessation
- 2000-07-10 EP EP00949297A patent/EP1200099B1/de not_active Expired - Lifetime
- 2000-07-10 WO PCT/EP2000/006545 patent/WO2001005382A1/en not_active Ceased
- 2000-07-10 PT PT00949297T patent/PT1200099E/pt unknown
- 2000-07-10 DE DE60003189T patent/DE60003189T2/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2001005382A8 (en)	2001-04-12
WO2001005382A1 (en)	2001-01-25
EP1200099A1 (de)	2002-05-02
DE60003189D1 (de)	2003-07-10
DK1200099T3 (da)	2003-07-21
PT1200099E (pt)	2003-08-29
JP2003504394A (ja)	2003-02-04
AU6271100A (en)	2001-02-05
EP1200099B1 (de)	2003-06-04
GB9916882D0 (en)	1999-09-22
DE60003189T2 (de)	2003-12-18
ES2195922T3 (es)	2003-12-16

Similar Documents

Publication	Publication Date	Title
MY135985A (en)	2008-07-31	Antitumor synergistic composition.
GB0025173D0 (en)	2000-11-29	Therapeutic agents
DE60112974D1 (en)	2005-09-29	Carbolinderivate
BG106586A (en)	2003-01-31	Pyrazolopyramidines as therapeutic agents
BG105270A (en)	2001-11-30	Tetrahydropyridoethers
PT815087E (pt)	2002-04-29	Derivados de fenilo trissubstituidos
IL149402A0 (en)	2002-11-10	Arylamine derivatives and their use as anti-telomerase agent
DE60216233D1 (en)	2007-01-04	Carbolinderivate
GT199900208A (es)	2001-05-31	Antibiòticos cetòlidos carbamato y carbazato.
MXPA03010761A (es)	2004-03-02	Combinaciones farmaceuticas.
BR9908391A (pt)	2000-10-31	Composição antitumural contendo uma combinação sinergìstica de um derivado de antraciclina com um derivado de camptotecina
HRPK20030734B3 (en)	2006-11-30	A combination comprising combretastatin and anticancer agents
BG102250A (en)	1999-02-26	The use of marigold-extracted glycosides for the treatment of psoriasis
AR032432A1 (es)	2003-11-12	Combinaciones oncoliticas para el tratamiento de cancer
DE69907926D1 (de)	2003-06-18	1,2,4-triazol-3-thion verbindungen
BR0309996A (pt)	2005-02-22	Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
ATE241991T1 (de)	2003-06-15	Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthält
TW200504051A (en)	2005-02-01	Novel acridine derivatives and their use as medicaments
MXPA02012209A (es)	2003-06-04	Terapia combinada contra tumores que comprende derivados de bistamicina acriloilo substituida y agentes de alquilacion.
YU46302A (sh)	2005-06-10	Supstituisani piroli
IL153178A0 (en)	2003-06-24	Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
BR0008454A (pt)	2002-01-29	Composição sinergìstica anti-tumoral
PT1551850E (pt)	2006-10-31	2 oxo-voruscharina e seus derivados
TWI231815B (en)	2005-05-01	Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents

Legal Events

Date

Code

Title

Description

2003-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1200099

Country of ref document: EP

2007-04-15

REN

Ceased due to non-payment of the annual fee